Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Hemophilia B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03549871
What this trial is testing

Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 80
Very early researchUnknownNCT06125756
What this trial is testing

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Who this might be right for
Hemophilia B Without Inhibitor
Affiliated Hospital of Guangdong Medical University 9
Large-scale testing (Phase 3)Study completedNCT02263456
What this trial is testing

Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B

Who this might be right for
Haemophilia B
Bio Products Laboratory
Large-scale testing (Phase 3)Looking for participantsNCT07080905
What this trial is testing

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 20
Large-scale testing (Phase 3)Study completedNCT00243659
What this trial is testing

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 30
Early research (Phase 1)WithdrawnNCT03996486
What this trial is testing

Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia

Who this might be right for
Hemophilia
Bayer
Post-approval studies (Phase 4)Study completedNCT00638001
What this trial is testing

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Who this might be right for
Haemophilia AHaemophilia B
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Large-scale testing (Phase 3)Study completedNCT00093210
What this trial is testing

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableLooking for participantsNCT04817462
What this trial is testing

Liver Biopsy In Haemophilia Gene Therapy

Who this might be right for
Hemophilia B, SevereHemophilia A, Severe
University College, London 10
Post-approval studies (Phase 4)UnknownNCT04108260
What this trial is testing

The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients

Who this might be right for
Hemophilia
National Taiwan University Hospital 5
Testing effectiveness (Phase 2)Study completedNCT01361126
What this trial is testing

A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 17
Large-scale testing (Phase 3)Looking for participantsNCT06003387
What this trial is testing

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

Who this might be right for
Hemophilia B
CSL Behring 35
Post-approval studies (Phase 4)Study completedNCT01561391
What this trial is testing

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 36
Large-scale testing (Phase 3)Study completedNCT02231944
What this trial is testing

An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients

Who this might be right for
Haemophilia B
Bio Products Laboratory
Testing effectiveness (Phase 2)Ended earlyNCT00076557
What this trial is testing

Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B

Who this might be right for
Hemophilia B
Avigen 15
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Study completedNCT03489291
What this trial is testing

Dose Confirmation Trial of AAV5-hFIXco-Padua

Who this might be right for
Hemophilia B
CSL Behring 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Not applicableStudy completedNCT02971969
What this trial is testing

Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Ultragenyx Pharmaceutical Inc 6
Large-scale testing (Phase 3)Active Not RecruitingNCT03861273
What this trial is testing

Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 51
Next Page